Recent Finacing
Recent Raise
Good Therapeutics designs context-dependent protein therapeutics and algorithms that switch cytokines from inactive to active upon target/biomarker binding, focusing on PD-1–targeted IL-2 immuno-oncology agents.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
See the team members at Good Therapeutics.
